Imaging Immune Therapies in Brain Tumor PatientsQ&A with Samuel Cheshier, M.D., Ph.D.
Brain tumors are the most common type of cancer occurring in children aged 14 and younger—as well as the leading cause of cancer death in that age group. Pediatric neurosurgeon Samuel Cheshier is working on new technologies to improve immunotherapy treatments and track their effectiveness over time.
The Science of Educating Special Needs Children
Capitol Hill Briefing, in Washington, DC: The increase in diagnoses of children with special needs has presented unique challenges in their education and development. What are leading scientists working on to confront these challenges?
Designing a Plan for Drug Discovery in Rare Pediatric Neurodegenerative Disease
There are currently no cures for neurodegenerative diseases, including Batten disease, a rare and fatal disorder affecting young children. While researchers have made headway in preventing genetic disorders through preconception carrier screenings and have found potential drug targets, the gap between basic research and clinical treatment development remains. To overcome this gap, researchers in academia and the pharmaceutical industry, supported by government agencies and nonprofit institutions, must come together to share expertise and promote translational research.